Ludwig researchers uncover novel mechanism by which tumors evade cancer immunotherapies

(Ludwig Institute for Cancer Research) A Ludwig Cancer Research study led by Benoit Van den Eynde, Director of Ludwig Brussels, has identified a novel mechanism by which tumors of the aggressive skin cancer melanoma can resist cancer immunotherapy.